Masao Hirota

566 total citations
22 papers, 473 citations indexed

About

Masao Hirota is a scholar working on Molecular Biology, Immunology and Pharmacology. According to data from OpenAlex, Masao Hirota has authored 22 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Immunology and 4 papers in Pharmacology. Recurrent topics in Masao Hirota's work include interferon and immune responses (3 papers), RNA Interference and Gene Delivery (3 papers) and Advanced biosensing and bioanalysis techniques (3 papers). Masao Hirota is often cited by papers focused on interferon and immune responses (3 papers), RNA Interference and Gene Delivery (3 papers) and Advanced biosensing and bioanalysis techniques (3 papers). Masao Hirota collaborates with scholars based in Japan, Sweden and Italy. Masao Hirota's co-authors include Yuichi Ishikawa, Nebojša Janjić, Shashi Kumar Gupta, Jeffrey D. Carter, Thale C. Jarvis, Yoshiko Furukawa, Tomoki Suzuki, Daniel J. Schneider, Cecilia Laterza and Emanuela Monni and has published in prestigious journals such as Journal of Biological Chemistry, Free Radical Biology and Medicine and Journal of Controlled Release.

In The Last Decade

Masao Hirota

21 papers receiving 454 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masao Hirota Japan 9 315 76 66 44 41 22 473
Anne Wijkhuisen France 13 278 0.9× 59 0.8× 107 1.6× 37 0.8× 36 0.9× 33 559
Redwan Huq United States 13 391 1.2× 89 1.2× 21 0.3× 17 0.4× 24 0.6× 17 525
Anthony Mukwaya Sweden 17 222 0.7× 69 0.9× 65 1.0× 53 1.2× 29 0.7× 27 647
Daniel R. Higazi United Kingdom 11 420 1.3× 26 0.3× 58 0.9× 44 1.0× 41 1.0× 18 643
Michael H. L. Nguyen United States 9 274 0.9× 291 3.8× 55 0.8× 35 0.8× 72 1.8× 20 724
Rebecca C. Allsopp United Kingdom 17 340 1.1× 45 0.6× 26 0.4× 41 0.9× 71 1.7× 24 672
Daniel E. Maidana United States 13 248 0.8× 81 1.1× 33 0.5× 22 0.5× 19 0.5× 23 523
Milan Ganguly United States 9 118 0.4× 37 0.5× 76 1.2× 28 0.6× 21 0.5× 19 395
Bjoern von Einem Germany 10 207 0.7× 24 0.3× 17 0.3× 72 1.6× 18 0.4× 20 429
Kyle Hurth United States 13 182 0.6× 29 0.4× 35 0.5× 17 0.4× 59 1.4× 46 599

Countries citing papers authored by Masao Hirota

Since Specialization
Citations

This map shows the geographic impact of Masao Hirota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masao Hirota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masao Hirota more than expected).

Fields of papers citing papers by Masao Hirota

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masao Hirota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masao Hirota. The network helps show where Masao Hirota may publish in the future.

Co-authorship network of co-authors of Masao Hirota

This figure shows the co-authorship network connecting the top 25 collaborators of Masao Hirota. A scholar is included among the top collaborators of Masao Hirota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masao Hirota. Masao Hirota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kiguchi, Toru, Masaki Yamaguchi, Naoki Takezako, et al.. (2021). Efficacy and safety of Wilms’ tumor 1 helper peptide OCV-501 in elderly patients with acute myeloid leukemia: a multicenter, randomized, double-blind, placebo-controlled phase 2 trial. Cancer Immunology Immunotherapy. 71(6). 1419–1430. 6 indexed citations
2.
Ge, Ruimin, Daniel Tornero, Masao Hirota, et al.. (2017). Choroid plexus-cerebrospinal fluid route for monocyte-derived macrophages after stroke. Journal of Neuroinflammation. 14(1). 153–153. 75 indexed citations
3.
Hirota, Masao, Yuichi Ishikawa, Tomoki Suzuki, et al.. (2015). Chemically Modified Interleukin-6 Aptamer Inhibits Development of Collagen-Induced Arthritis in Cynomolgus Monkeys. Nucleic Acid Therapeutics. 26(1). 10–19. 30 indexed citations
4.
Gupta, Shashi Kumar, Masao Hirota, Sheela Waugh, et al.. (2014). Chemically Modified DNA Aptamers Bind Interleukin-6 with High Affinity and Inhibit Signaling by Blocking Its Interaction with Interleukin-6 Receptor. Journal of Biological Chemistry. 289(12). 8706–8719. 125 indexed citations
5.
Gelinas, Amy D., D.R. Davies, Thomas E. Edwards, et al.. (2014). Crystal Structure of Interleukin-6 in Complex with a Modified Nucleic Acid Ligand. Journal of Biological Chemistry. 289(12). 8720–8734. 84 indexed citations
6.
Ikeda, Hitoshi, Mina Ogawa, Masao Hirota, et al.. (2009). Orbit Determination and Gravity Estimation Results of KAGUYA: from Nominal Observation Phase to Extended Mission Phase. 2 indexed citations
7.
Miyake, Masateru, Masao Hirota, Hajime Toguchi, et al.. (2006). Novel oral formulation safely improving intestinal absorption of poorly absorbable drugs: Utilization of polyamines and bile acids. Journal of Controlled Release. 111(1-2). 27–34. 36 indexed citations
8.
9.
Niwa, Masayuki, et al.. (2004). p38 mapk associated with stereoselective priming by grepafloxacin on o2− production in neutrophils. Free Radical Biology and Medicine. 36(10). 1259–1269. 5 indexed citations
10.
Yamamoto, Hiroshi, Tomonobu Koizumi, Masao Hirota, et al.. (2002). Lung Tissue Distribution After Intravenous Administration of Grepafloxacin: Comparative Study With Levofloxacin. The Japanese Journal of Pharmacology. 88(1). 63–68. 3 indexed citations
11.
Niwa, Masayuki, Yutaka Kanamori, Hiroyuki Matsuno, et al.. (2001). Differential uptake of grepafloxacin by human circulating blood neutrophils and those exudated into tissues. European Journal of Pharmacology. 428(1). 121–126. 6 indexed citations
12.
13.
Maeda, Masatoshi, et al.. (1997). ADEOS/RIS laser tracking experiments. 403. 131. 2 indexed citations
14.
Furukawa, Yoshiko, et al.. (1995). Interferons Suppress Nerve Growth Factor Synthesis as a Result of Interference with Cell Growth in Astrocytes Cultured from Neonatal Mouse Brain. Journal of Neurochemistry. 64(4). 1476–1482. 12 indexed citations
15.
Hirota, Masao, et al.. (1994). Changes in nerve growth factor content of the submaxillary gland in the genetically dystrophic (mdx) mouse. Journal of the Neurological Sciences. 121(2). 176–182. 6 indexed citations
16.
Hirota, Masao, et al.. (1994). pS2 gene especially expressed in the late G1/S phase of mouse astrocytes. Neuroscience Letters. 171(1-2). 49–51. 16 indexed citations
17.
Hirota, Masao, et al.. (1994). Effect of Basic Fibroblast Growth Factor on Synthesis/Secretion of pS2 Protein by Human Breast Cancer Cells (MCF‐7). European Journal of Biochemistry. 225(3). 1041–1046. 8 indexed citations
18.
Hirota, Masao, et al.. (1994). Cytokine regulation of PS2 gene expression in mouse astrocytes.. PubMed. 33(3). 515–20. 20 indexed citations
19.
Hirota, Masao, et al.. (1985). Some useful coordinate systems to discuss the apogee motor firing optimization. Acta Astronautica. 12(10). 831–836. 1 indexed citations
20.
Okamoto, Go, et al.. (1955). (268) Corrosion of Mild Steel in the Ammonical Solution of Cupric Salts. The Journal of the Society of Chemical Industry Japan. 58(11). 881–885.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne Wijkhuisen Breakdown of academic impact, for papers by Redwan Huq Breakdown of academic impact, for papers by Anthony Mukwaya Breakdown of academic impact, for papers by Daniel R. Higazi Breakdown of academic impact, for papers by Michael H. L. Nguyen Breakdown of academic impact, for papers by Rebecca C. Allsopp Breakdown of academic impact, for papers by Daniel E. Maidana Breakdown of academic impact, for papers by Milan Ganguly Breakdown of academic impact, for papers by Bjoern von Einem Breakdown of academic impact, for papers by Kyle Hurth
Rankless by CCL
2026